Brevan Howard Capital Management’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$310K Buy
+22,055
New +$313K ﹤0.01% 1558
2026
Q2
– Sell
-15,031
Closed -$215K – 2570
2026
Q1
$215K Sell
15,031
-35,498
-70% -$431K ﹤0.01% 1852
2025
Q4
$499K Buy
+50,529
New +$488K 0.01% 1109
2025
Q2
– Sell
-22,836
Closed -$213K – 2008
2025
Q1
$213K Buy
+22,836
New +$235K ﹤0.01% 961
2024
Q4
– Sell
-23,236
Closed -$302K – 1415
2024
Q3
$302K Buy
23,236
+6,799
+41% +$98.2K ﹤0.01% 858
2024
Q2
$236K Buy
16,437
+3,589
+28% +$58.9K ﹤0.01% 848
2024
Q1
$223K Buy
+12,848
New +$185K ﹤0.01% 760

Other funds holding SWBI

Brevan Howard Capital Management's SWBI Position: Q3 2026 in Review

Brevan Howard Capital Management opened a new position in Smith & Wesson (SWBI) in Q3 2026: 22,055 shares worth $310K. The stake represents ﹤0.01% of the portfolio and ranks #1558 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in SWBI as recently as Q1 2026.

Brevan Howard Capital Management first reported a position in SWBI in Q1 2024 and has held it in 7 quarters since. The position peaked at $499K in Q4 2025. 195 funds tracked by Wall St. Rank hold SWBI as of Q3 2026.

  • Brevan Howard Capital Management held 22,055 shares of Smith & Wesson worth $310K as of Q3 2026.
  • Smith & Wesson was a new Brevan Howard Capital Management position in Q3 2026.
  • Smith & Wesson made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q3 2026, its #1558 holding.
  • Brevan Howard Capital Management first reported a position in Smith & Wesson in Q1 2024 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Smith & Wesson position peaked at $499K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Smith & Wesson as of Q3 2026.

Based on Brevan Howard Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.